Get started
Author

Shiwei Gong

Observed name: Shi-wei Gong
ORCID: 0000-0003-3556-8512
Observed ORCID: 0000-0003-3556-8512
OpenAlex ID: A5043617637
Impact of universal medical insurance system on the accessibility of medical service supply and affordability of patients in China
2018 · Xiaolei Xiong, Zhiguo Zhang, et al. · PLoS ONE · 97
PDF
The availability and affordability of orphan drugs for rare diseases in China
2016 · Shiwei Gong, Yingxiao Wang, et al. · Orphanet Journal of Rare Diseases · 73
PDF
Why is misdiagnosis more likely among some people with rare diseases than others? Insights from a population-based cross-sectional study in China
2020 · Dong Dong, Roger Yat-Nork Chung, et al. · Orphanet Journal of Rare Diseases · 65
PDF
The availability, price and affordability of antidiabetic drugs in Hubei province, China
2018 · Shiwei Gong, Hongbing Cai, et al. · Health Policy and Planning · 47
PDF
Characteristic analysis of adverse reactions of five anti-TNFɑ agents: a descriptive analysis from WHO-VigiAccess
2023 · Mingming Li, Ruxu You, et al. · Frontiers in Pharmacology · 32
Patients' attitudes towards switching to national volume-based procurement (NVBP) Drugs—a qualitative investigation in Wuhan, China
2023 · Jinyi Tao, Shihong Li, et al. · BMC Health Services Research · 19
PDF
How Do Patients and Doctors Perceive Medical Services for Rare Diseases Differently in China? Insights from Two National Surveys
2020 · Shiwei Gong, Dehe Li, et al. · International Journal of Environmental Research and Public Health · 18
PDF
The availability, price and affordability of essential antibacterials in Hubei province, China
2018 · Guangjie Wu, Shiwei Gong, et al. · BMC Health Services Research · 14
PDF
Smoking is associated with elevated blood level of volatile organic compounds: a population-based analysis of NHANES 2017–2018
2023 · Guangjie Wu, Shiwei Gong, et al. · Archives of Public Health · 12
PDF
Is sub-national healthcare social protection sufficient for protecting rare disease patients? the case of China
2023 · Juan Xu, Mingren Yu, et al. · Frontiers in Public Health · 10
Social activity as mediator between social support and psychological quality of life among people with rare diseases: A national repetitive cross-sectional study
2022 · Shanquan Chen, Yuqi Wang, et al. · Journal of Psychiatric Research · 10
Preferences of patients with depression for exercises: a discrete choice experiment
2025 · Hui-qin Li, Peng Xie, et al. · BMC Public Health · 5
Perceptions of Generic Drugs in the Pharmacists of Public Hospitals: A Cross-sectional Survey in Hubei Province of China
2021 · Wei-jie Li, Mei-jun Xia, et al. · Current Medical Science · 5
Diagnosis of Drug-Resistant Tuberculosis: Rapid Evaluation of Drug Susceptibility with Nanopore Targeted Sequencing
2025 · Jun Chen, Qijing Fan, et al. · Clinical Chemistry · 4
Psychiatric nurses’ preferences for job: a discrete choice experiment
2025 · Hui-qin Li, Peng Xie, et al. · BMC Nursing · 3
Availability and Affordability of Therapeutic Monoclonal Antibodies After the New Medical Reform in Hubei Province, China
2022 · Yu-feng Ding, Jin-wen Zhang, et al. · Current Medical Science · 2
Diagnostic performance of nanopore-targeted sequencing for pulmonary infections in a tuberculosis-endemic setting: A prospective observational study
2026 · Qijing Fan, Jun Chen, et al. · International Journal of Infectious Diseases · 1
PDF
Deciphering the population dynamics and drug-resistance characteristics of extrapulmonary tuberculosis: genomic and clinical insights from a Chinese hospital
2025 · Shiwei Gong, Xinyue Li, et al. · Frontiers in Cellular and Infection Microbiology · 1
PDF
Application of Failure Mode and Effects Analysis (FMEA) to Optimize Acute Kidney Injury Management Process- a multicenter study in China
2024 · Qiling Xu, Fang Cheng, et al. · Research Square
PDF
Changes in Availability and Affordability of Therapeutic Monoclonal Antibodies After New Medical Reform in Hubei Province, China
2020 · Yufeng Ding, Jinwen Zhang, et al.
PDF
Changes in Availability and Affordability of Therapeutic Monoclonal Antibodies After New Medical Reform in Hubei Province, China
2020 · Yufeng Ding, Jinwen Zhang, et al.
PDF
Discussion on public-private partnership for emergency drug supply management system in China
2017 · Xiaolei Xiong, Tianhui Li, et al. · Zhonghua yiyuan guanli zazhi
Works count: 22
Citation count: 418
H-index: 10
I10-index: 11
Year
Topic
Type